These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 21454955)

  • 1. Induction of antibodies binding to the membrane proximal external region of gp36 of HIV-2.
    Behrendt R; Fiebig U; Kurth R; Denner J
    Intervirology; 2012; 55(3):252-6. PubMed ID: 21454955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice.
    Zhou M; Kostoula I; Brill B; Panou E; Sakarellos-Daitsiotis M; Dietrich U
    Vaccine; 2012 Mar; 30(11):1911-6. PubMed ID: 22269872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
    Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of interaction between the HIV-1-neutralizing monoclonal antibody 2F5 and its epitope.
    Fiebig U; Schmolke M; Eschricht M; Kurth R; Denner J
    AIDS; 2009 May; 23(8):887-95. PubMed ID: 19414989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HIV-1 antibodies 2F5 and 4E10 interact differently with lipids to bind their epitopes.
    Franquelim HG; Chiantia S; Veiga AS; Santos NC; Schwille P; Castanho MA
    AIDS; 2011 Feb; 25(4):419-28. PubMed ID: 21245727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.
    Luo M; Yuan F; Liu Y; Jiang S; Song X; Jiang P; Yin X; Ding M; Deng H
    Vaccine; 2006 Jan; 24(4):435-42. PubMed ID: 16143433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.
    Matyas GR; Wieczorek L; Beck Z; Ochsenbauer-Jambor C; Kappes JC; Michael NL; Polonis VR; Alving CR
    AIDS; 2009 Oct; 23(16):2069-77. PubMed ID: 19710597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with hybrid proteins containing the membrane proximal external region of HIV-1.
    Strasz N; Morozov VA; Kreutzberger J; Keller M; Eschricht M; Denner J
    AIDS Res Hum Retroviruses; 2014 May; 30(5):498-508. PubMed ID: 24392780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and analysis of the membrane proximal external region epitopes of HIV-1.
    Ingale S; Gach JS; Zwick MB; Dawson PE
    J Pept Sci; 2010 Dec; 16(12):716-22. PubMed ID: 21104968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a trimeric MPER containing HIV-1 gp41 antigen.
    Hinz A; Schoehn G; Quendler H; Hulsik DL; Stiegler G; Katinger H; Seaman MS; Montefiori D; Weissenhorn W
    Virology; 2009 Aug; 390(2):221-7. PubMed ID: 19539967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards an AIDS vaccine: the transmembrane envelope protein as target for broadly neutralizing antibodies.
    Denner J
    Hum Vaccin; 2011; 7 Suppl():4-9. PubMed ID: 21266839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designed recombinant adenovirus type 5 vector induced envelope-specific CD8(+) cytotoxic T lymphocytes and cross-reactive neutralizing antibodies against human immunodeficiency virus type 1.
    Ura T; Yoshida A; Xin KQ; Yoshizaki S; Yashima S; Abe S; Mizuguchi H; Okuda K
    J Gene Med; 2009 Feb; 11(2):139-49. PubMed ID: 19065543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity.
    Braibant M; Brunet S; Costagliola D; Rouzioux C; Agut H; Katinger H; Autran B; Barin F
    AIDS; 2006 Oct; 20(15):1923-30. PubMed ID: 16988513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity.
    Cham F; Zhang PF; Heyndrickx L; Bouma P; Zhong P; Katinger H; Robinson J; van der Groen G; Quinnan GV
    Virology; 2006 Mar; 347(1):36-51. PubMed ID: 16378633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
    Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI
    Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new paradigm in molecular recognition? Specific antibody binding to membrane-inserted HIV-1 epitopes.
    Nieva JL; Apellaniz B; Huarte N; Lorizate M
    J Mol Recognit; 2011; 24(4):642-6. PubMed ID: 21584875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid modulation of membrane-bound epitope recognition and blocking by HIV-1 neutralizing antibodies.
    Huarte N; Lorizate M; Kunert R; Nieva JL
    FEBS Lett; 2008 Nov; 582(27):3798-804. PubMed ID: 18930052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological properties of the transmembrane envelope protein of the feline foamy virus and its use for serological screening.
    Mühle M; Bleiholder A; Kolb S; Hübner J; Löchelt M; Denner J
    Virology; 2011 Apr; 412(2):333-40. PubMed ID: 21316070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity.
    Scherer EM; Zwick MB; Teyton L; Burton DR
    AIDS; 2007 Oct; 21(16):2131-9. PubMed ID: 18090039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Rhinovirus Presenting 4E10 Epitope of HIV-1 MPER Elicits Neutralizing Antibodies in Human ICAM-1 Transgenic Mice.
    Yi G; Tu X; Bharaj P; Guo H; Zhang J; Shankar P; Manjunath N
    Mol Ther; 2015 Oct; 23(10):1663-70. PubMed ID: 26061648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.